SCHEMBL5419975

SCHEMBL5419975

Cc1cn2cc(C(=O)N(C)C)c(C/C=C/c3ccccc3)c(O)c2n1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
P2RX3 P56373 1/20 0.33
HDAC1 Q13547 3/20 0.33
HDAC6 Q9UBN7 2/20 0.33
HDAC2 Q92769 1/20 0.33
PAM P19021 1/20 0.33
P2RX7 Q99572 1/20 0.32
BCHE P06276 1/20 0.32
PTGER4 P35408 1/20 0.32
PTGER3 P43115 1/20 0.32
PTGER2 P43116 1/20 0.32
MAPT P10636 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
CXCR1 P25024 1/20 0.31
CXCR2 P25025 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5419979 1.00 RAB9A (0.37) RAB9AALDH1A1KDM4EP2RX3HDAC1
SCHEMBL5570709 0.84 ATP4A (0.40) RAB9AALDH1A1KDM4EP2RX3HDAC1
SCHEMBL5570706 0.84 ATP4A (0.40) RAB9AALDH1A1KDM4EP2RX3HDAC1
Alcohol SCHEMBL5567725 0.78 KDM4E (0.36) ALDH1A1KDM4E
SCHEMBL5427747 0.77 CXCR2 (0.34) ALDH1A1P2RX7CXCR1CXCR2
SCHEMBL4600666 0.76 ALDH1A1 (0.43) RAB9AALDH1A1KDM4EHDAC1HDAC6
SCHEMBL4600661 0.76 ALDH1A1 (0.43) RAB9AALDH1A1KDM4EHDAC1HDAC6
SCHEMBL4600103 0.70 ALDH1A1 (0.34) RAB9AALDH1A1KDM4E
SCHEMBL5567375 0.69 ALDH1A1 (0.33) RAB9AALDH1A1KDM4E
SCHEMBL5567379 0.69 ALDH1A1 (0.33) RAB9AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070191334-A1 Tricyclic imidazopyridines ALTANA PHARMA AG (DE) 2007-08-16 US disclosed
EP-1735318-A2 7H-8,9-DIHYDRO-PYRANO(2,3-C)IMIDAZO(1,2A)PYRIDINE DERIVATIVES AND THEIR USE AS GASTRIC ACID SECRETION INHIBITORS Altana Pharma AG (DE) 2006-12-27 EP disclosed
WO-2005090358-A2 7H-8,9-DIHYDRO-PYRANO (2,3-C) IMIDAZO (1,2A) PYRIDINE DERIVATIVES AND THEIR USE AS GASTRIC ACID SECRETION INHIBITORS ALTANA PHARMA AG (DE) 2005-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191334-A1 Tricyclic imidazopyridines GIPR, SLC10A2, MLNR RAB9A 1890/4885ALDH1A1 823/4885KDM4E 3809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.